169 related articles for article (PubMed ID: 22014457)
1. Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.
Mugabe C; Raven PA; Fazli L; Baker JH; Jackson JK; Liggins RT; So AI; Gleave ME; Minchinton AI; Brooks DE; Burt HM
Biomaterials; 2012 Jan; 33(2):692-703. PubMed ID: 22014457
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancer.
Mugabe C; Matsui Y; So AI; Gleave ME; Heller M; Zeisser-Labouèbe M; Heller L; Chafeeva I; Brooks DE; Burt HM
Biomacromolecules; 2011 Apr; 12(4):949-60. PubMed ID: 21355626
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin.
Ye L; Letchford K; Heller M; Liggins R; Guan D; Kizhakkedathu JN; Brooks DE; Jackson JK; Burt HM
Biomacromolecules; 2011 Jan; 12(1):145-55. PubMed ID: 21128674
[TBL] [Abstract][Full Text] [Related]
6. The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.
Tsallas A; Jackson J; Burt H
Cancer Chemother Pharmacol; 2011 Aug; 68(2):431-44. PubMed ID: 21069339
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
Mugabe C; Hadaschik BA; Kainthan RK; Brooks DE; So AI; Gleave ME; Burt HM
BJU Int; 2009 Apr; 103(7):978-86. PubMed ID: 19007363
[TBL] [Abstract][Full Text] [Related]
8. Tissue Permeability Effects Associated with the Use of Mucoadhesive Cationic Nanoformulations of Docetaxel in the Bladder.
Pandey R; Jackson JK; Mugabe C; Liggins R; Burt HM
Pharm Res; 2016 Aug; 33(8):1850-61. PubMed ID: 27091034
[TBL] [Abstract][Full Text] [Related]
9. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
10. Enhanced taxane uptake into bladder tissues following co-administration with either mitomycin C, doxorubicin or gemcitabine: association to exfoliation processes.
Pandey R; Jackson JK; Liggins R; Mugabe C; Burt HM
BJU Int; 2018 Nov; 122(5):898-908. PubMed ID: 29862643
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapy.
Lu S; Neoh KG; Kang ET; Mahendran R; Chiong E
Eur J Pharm Sci; 2015 May; 72():57-68. PubMed ID: 25772330
[TBL] [Abstract][Full Text] [Related]
12. Investigation of hydrophobically derivatized hyperbranched polyglycerol with PEGylated shell as a nanocarrier for systemic delivery of chemotherapeutics.
Misri R; Wong NK; Shenoi RA; Lum CM; Chafeeva I; Toth K; Rustum Y; Kizhakkedathu JN; Khan MK
Nanomedicine; 2015 Oct; 11(7):1785-95. PubMed ID: 25981338
[TBL] [Abstract][Full Text] [Related]
13. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse.
Nativ O; Dalal E; Hidas G; Aronson M
Int J Urol; 2006 Oct; 13(10):1344-6. PubMed ID: 17010016
[TBL] [Abstract][Full Text] [Related]
14. Bladder permeability barrier: recovery from selective injury of surface epithelial cells.
Lavelle J; Meyers S; Ramage R; Bastacky S; Doty D; Apodaca G; Zeidel ML
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F242-53. PubMed ID: 12110507
[TBL] [Abstract][Full Text] [Related]
15. Design Considerations for Developing Hyperbranched Polyglycerol Nanoparticles as Systemic Drug Carriers.
Wong NK; Misri R; Shenoi RA; Chafeeva I; Kizhakkedathu JN; Khan MK
J Biomed Nanotechnol; 2016 May; 12(5):1089-100. PubMed ID: 27305828
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG
Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001
[TBL] [Abstract][Full Text] [Related]
17. A hydrotropic β-cyclodextrin grafted hyperbranched polyglycerol co-polymer for hydrophobic drug delivery.
Zhang X; Zhang X; Wu Z; Gao X; Cheng C; Wang Z; Li C
Acta Biomater; 2011 Feb; 7(2):585-92. PubMed ID: 20813209
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible hyperbranched polyglycerol modified β-cyclodextrin derivatives for docetaxel delivery.
Xu Z; Zhang Y; Hu Q; Tang Q; Xu J; Wu J; Kirk TB; Ma D; Xue W
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():965-972. PubMed ID: 27987795
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.
Çetinel S; Çanıllıoğlu YE; Çikler E; Sener G; Ercan F
BJU Int; 2011 Apr; 107(8):1320-5. PubMed ID: 20735385
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy.
Elsen S; Lerut E; Van Cleynenbreugel B; van der Aa F; van Poppel H; de Witte PA
BJU Int; 2015 Sep; 116(3):468-77. PubMed ID: 25754262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
